{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T12:39:46Z","timestamp":1766579986070},"reference-count":62,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T00:00:00Z","timestamp":1536192000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nefrolog\u00eda"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.nefro.2018.07.004","type":"journal-article","created":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T19:34:26Z","timestamp":1538163266000},"page":"18-28","source":"Crossref","is-referenced-by-count":20,"title":["Native vitamin D in pre-dialysis chronic kidney disease"],"prefix":"10.1016","volume":"39","author":[{"given":"Mariana P.","family":"Cardoso","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciano A.L.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nefro.2018.07.004_bib0315","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1053\/j.ajkd.2014.09.023","article-title":"The future burden of CKD in the United States: a simulation model for the CDC CKD initiative","volume":"65","author":"Hoerger","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nefro.2018.07.004_bib0320","first-page":"510","article-title":"Relative importance of the determinants of serum levels of 25-hydroxy vitamin D in patients with chronic kidney disease","volume":"36","author":"Caravaca-Fontan","year":"2016","journal-title":"Nefrologia"},{"key":"10.1016\/j.nefro.2018.07.004_bib0325","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1053\/j.ajkd.2011.04.028","article-title":"Low 25-hydroxyvitamin D levels and mortality in non-dialysis-dependent CKD","volume":"58","author":"Navaneethan","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nefro.2018.07.004_bib0330","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/ki.2008.501","article-title":"Vitamin D levels and patient outcome in chronic kidney disease","volume":"75","author":"Ravani","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.nefro.2018.07.004_bib0335","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra070553","article-title":"Vitamin D deficiency","volume":"357","author":"Holick","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nefro.2018.07.004_bib0340","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2147\/IJNRD.S97637","article-title":"Vitamin D prohormone in the treatment of secondary hyperparathyroidism in patients with chronic kidney disease","volume":"10","author":"Friedl","year":"2017","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"10.1016\/j.nefro.2018.07.004_bib0345","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.kisu.2017.04.001","article-title":"KDIGO 2017 Clinical Practice Guideline update for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)","volume":"7","year":"2017","journal-title":"Kidney Int Suppl (2011)"},{"key":"10.1016\/j.nefro.2018.07.004_bib0350","doi-asserted-by":"crossref","first-page":"118","DOI":"10.4161\/derm.20014","article-title":"Vitamin D supplementation in pre-dialysis chronic kidney disease: a systematic review","volume":"4","author":"Alvarez","year":"2012","journal-title":"Dermatoendocrinology"},{"key":"10.1016\/j.nefro.2018.07.004_bib0355","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.beem.2011.05.005","article-title":"Vitamin D in chronic kidney disease","volume":"25","author":"Dusso","year":"2011","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.nefro.2018.07.004_bib0360","doi-asserted-by":"crossref","first-page":"F8","DOI":"10.1152\/ajprenal.00336.2004","article-title":"Vitamin D","volume":"289","author":"Dusso","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.nefro.2018.07.004_bib0365","doi-asserted-by":"crossref","first-page":"122","DOI":"10.5455\/msm.2015.27.122-124","article-title":"Vitamin D in the patients with chronic kidney disease: when, to whom and in which form","volume":"27","author":"Pavlovic","year":"2015","journal-title":"Mater Sociomed"},{"key":"10.1016\/j.nefro.2018.07.004_bib0370","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1056\/NEJMcp1009570","article-title":"Clinical practice Vitamin D insufficiency","volume":"364","author":"Rosen","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nefro.2018.07.004_bib0375","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/kisup.2011.30","article-title":"Kidney disease and vitamin D levels: 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and VDR activation","volume":"1","author":"Dusso","year":"2011","journal-title":"Kidney Int Suppl (2011)"},{"key":"10.1016\/j.nefro.2018.07.004_bib0380","first-page":"S1","article-title":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)","year":"2009","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.nefro.2018.07.004_bib0385","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/bonekey.2013.232","article-title":"and chronic kidney disease-mineral bone disease (CKD-MBD)","volume":"3","author":"Nigwekar","year":"2014","journal-title":"Bonekey Rep"},{"key":"10.1016\/j.nefro.2018.07.004_bib0390","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3109\/00365513.2012.744464","article-title":"Ergocalciferol treatment and aspects of mineral homeostasis in patients with chronic kidney disease stage 4\u20135","volume":"73","author":"Gravesen","year":"2013","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.nefro.2018.07.004_bib0395","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/ndt\/gfv340","article-title":"Vitamin D: a dynamic molecule. How relevant might the dynamism for a vitamin be?","volume":"31","author":"Mazzaferro","year":"2016","journal-title":"Nephrol Dial Transpl"},{"key":"10.1016\/j.nefro.2018.07.004_bib0400","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/ki.1988.190","article-title":"Extra-renal production of calcitriol in chronic renal failure","volume":"34","author":"Dusso","year":"1988","journal-title":"Kidney Int"},{"key":"10.1016\/j.nefro.2018.07.004_bib0405","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1159\/000369939","article-title":"Modified-release calcifediol effectively controls secondary hyperparathyroidism associated with vitamin D insufficiency in chronic kidney disease","volume":"40","author":"Sprague","year":"2014","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.nefro.2018.07.004_bib0410","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.2215\/CJN.05781207","article-title":"Hypovitaminosis D in chronic kidney disease","volume":"3","author":"Mehrotra","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6 Suppl.","key":"10.1016\/j.nefro.2018.07.004_bib0415","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1093\/ajcn\/80.6.1678S","article-title":"Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease","volume":"80","author":"Holick","year":"2004","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.nefro.2018.07.004_bib0420","doi-asserted-by":"crossref","DOI":"10.4172\/2161-0959.1000166","article-title":"Low dietary intake of vitamin D and vitamin D deficiency in hemodialysis patients","volume":"4","author":"Krassilnikova","year":"2014","journal-title":"J Nephrol Ther"},{"key":"10.1016\/j.nefro.2018.07.004_bib0425","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1681\/ASN.2009080815","article-title":"Reduced hepatic synthesis of calcidiol in uremia","volume":"21","author":"Michaud","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nefro.2018.07.004_bib0430","doi-asserted-by":"crossref","first-page":"5358","DOI":"10.1210\/en.2005-0777","article-title":"Dietary and serum phosphorus regulate fibroblast growth factor 23 expression and 1,25-dihydroxyvitamin D metabolism in mice","volume":"146","author":"Perwad","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.nefro.2018.07.004_bib0435","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1046\/j.1523-1755.2003.00114.x","article-title":"Gene expression of vitamin D hydroxylase and megalin in the remnant kidney of nephrectomized rats","volume":"64","author":"Takemoto","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.nefro.2018.07.004_bib0440","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/ajcn\/37.3.403","article-title":"Impaired intestinal absorption of vitamin D3 in azotemic rats","volume":"37","author":"Vaziri","year":"1983","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.nefro.2018.07.004_bib0445","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1053\/j.jrn.2011.02.001","article-title":"Risk factors for hypovitaminosis D in nondialyzed chronic kidney disease patients","volume":"22","author":"Figuiredo-Dias","year":"2012","journal-title":"J Ren Nutr"},{"key":"10.1016\/j.nefro.2018.07.004_bib0450","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1525-139X.2005.18408.x","article-title":"treatment in chronic kidney disease","volume":"18","author":"Andress","year":"2005","journal-title":"Semin Dial"},{"key":"10.1016\/j.nefro.2018.07.004_bib0455","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1210\/jcem-72-1-157","article-title":"Extrarenal production of calcitriol in normal and uremic humans","volume":"72","author":"Dusso","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.nefro.2018.07.004_bib0460","doi-asserted-by":"crossref","first-page":"917","DOI":"10.3109\/0886022X.2015.1043920","article-title":"Vitamin D supplements in chronic kidney disease","volume":"37","author":"Zhu","year":"2015","journal-title":"Ren Fail"},{"key":"10.1016\/j.nefro.2018.07.004_bib0465","doi-asserted-by":"crossref","first-page":"471","DOI":"10.5527\/wjn.v5.i5.471","article-title":"What is the optimal level of vitamin D in non-dialysis chronic kidney disease population?","volume":"5","author":"Molina","year":"2016","journal-title":"World J Nephrol"},{"key":"10.1016\/j.nefro.2018.07.004_bib0470","series-title":"Dietary reference intakes for calcium and vitamin D","article-title":"The National Academies Collection: Reports funded by National Institutes of Health","author":"Institute of Medicine Committee to Review Dietary Reference Intakes for Vitamin D, Calcium","year":"2011"},{"key":"10.1016\/j.nefro.2018.07.004_bib0475","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s40620-015-0186-0","article-title":"Current recommended 25-hydroxyvitamin D targets for chronic kidney disease management may be too low","volume":"29","author":"Ennis","year":"2016","journal-title":"J Nephrol"},{"issue":"Suppl. 3","key":"10.1016\/j.nefro.2018.07.004_bib0480","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease","volume":"42","author":"National Kidney Foundation","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nefro.2018.07.004_bib0485","doi-asserted-by":"crossref","first-page":"276","DOI":"10.5414\/CNP73276","article-title":"Treatment of vitamin D deficiency in CKD patients with ergocalciferol: are current K\/DOQI treatment guidelines adequate?","volume":"73","author":"Qunibi","year":"2010","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.nefro.2018.07.004_bib0490","first-page":"643","article-title":"Efficacy of high vs conventional ergocalciferol dose for increasing 25-hydroxyvitamin D and suppressing parathyroid hormone levels in Stage III\u2013IV CKD with vitamin D deficiency\/insufficiency: a randomized controlled trial","volume":"98","author":"Thimachai","year":"2015","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.nefro.2018.07.004_bib0495","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s40620-016-0305-6","volume":"29","author":"Morrone","year":"2016","journal-title":"J Nephrol"},{"issue":"Suppl. 1","key":"10.1016\/j.nefro.2018.07.004_bib0500","first-page":"3","article-title":"Spanish Society of Nephrology recommendations for controlling mineral and bone disorder in chronic kidney disease patients (S.E.N.-M.B.D.)","volume":"31","author":"Torregrosa","year":"2011","journal-title":"Nefrologia"},{"key":"10.1016\/j.nefro.2018.07.004_bib0505","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.1210\/jc.2014-1714","article-title":"25(OH)D2 half-life is shorter than 25(OH)D3 half-life and is influenced by DBP concentration and genotype","volume":"99","author":"Jones","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.nefro.2018.07.004_bib0510","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000430813","article-title":"Ergocalciferol versus cholecalciferol for nutritional vitamin D replacement in CKD","volume":"130","author":"Mangoo-Karim","year":"2015","journal-title":"Nephron"},{"key":"10.1016\/j.nefro.2018.07.004_bib0515","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/ajcn\/84.4.694","article-title":"The case against ergocalciferol (vitamin D2) as a vitamin supplement","volume":"84","author":"Houghton","year":"2006","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.nefro.2018.07.004_bib0520","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.3945\/ajcn.111.031070","article-title":"Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysis","volume":"95","author":"Tripkovic","year":"2012","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.nefro.2018.07.004_bib0525","doi-asserted-by":"crossref","first-page":"5387","DOI":"10.1210\/jc.2004-0360","article-title":"Vitamin D2 is much less effective than vitamin D3 in humans","volume":"89","author":"Armas","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.nefro.2018.07.004_bib0530","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000098561","article-title":"Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease","volume":"27","author":"Zisman","year":"2007","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.nefro.2018.07.004_bib0535","doi-asserted-by":"crossref","first-page":"e99461","DOI":"10.1371\/journal.pone.0099461","article-title":"Ergocalciferol and microcirculatory function in chronic kidney disease and concomitant vitamin D deficiency: an exploratory, double blind, randomised controlled trial","volume":"9","author":"Dreyer","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.nefro.2018.07.004_bib0540","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1159\/000157177","article-title":"Effects of long-term cholecalciferol supplementation on mineral metabolism and calciotropic hormones in chronic kidney disease","volume":"31","author":"Oksa","year":"2008","journal-title":"Kidney Blood Press Res"},{"key":"10.1016\/j.nefro.2018.07.004_bib0545","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1017\/S000711451600427X","article-title":"Cholecalciferol vs. ergocalciferol for 25-hydroxyvitamin D (25(OH)D) repletion in chronic kidney disease: a randomised clinical trial","volume":"116","author":"Wetmore","year":"2016","journal-title":"Br J Nutr"},{"key":"10.1016\/j.nefro.2018.07.004_bib0550","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1093\/ndt\/gfw080","article-title":"Con: nutritional vitamin D replacement in chronic kidney disease and end-stage renal disease","volume":"31","author":"Agarwal","year":"2016","journal-title":"Nephrol Dial Transpl"},{"key":"10.1016\/j.nefro.2018.07.004_bib0555","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1080\/17512433.2017.1371011","article-title":"Calcifediol to treat secondary hyperparathyroidism in patients with chronic kidney disease","volume":"10","author":"Galassi","year":"2017","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.nefro.2018.07.004_bib0560","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1159\/000450766","article-title":"Use of extended-release calcifediol to treat secondary hyperparathyroidism in stages 3 and 4 chronic kidney disease","volume":"44","author":"Sprague","year":"2016","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.nefro.2018.07.004_bib0565","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1053\/j.ajkd.2011.03.020","article-title":"Vitamin D status and mortality risk in CKD: a meta-analysis of prospective studies","volume":"58","author":"Pilz","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nefro.2018.07.004_bib0570","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1159\/000346846","article-title":"Vitamin D treatment and mortality in chronic kidney disease: a systematic review and meta-analysis","volume":"37","author":"Duranton","year":"2013","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.nefro.2018.07.004_bib0575","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.atherosclerosis.2011.10.023","article-title":"Vitamin D deficiency and endothelial dysfunction in non-dialysis chronic kidney disease patients","volume":"220","author":"Chitalia","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.nefro.2018.07.004_bib0580","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.5114\/aoms.2016.61911","article-title":"Subclinical cardiovascular disease markers and vitamin D deficiency in non-dialysis chronic kidney disease patients","volume":"12","author":"Capusa","year":"2016","journal-title":"Arch Med Sci"},{"key":"10.1016\/j.nefro.2018.07.004_bib0585","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1681\/ASN.2017010003","article-title":"A randomized trial of vitamin D supplementation on vascular function in CKD","volume":"28","author":"Kumar","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nefro.2018.07.004_bib0590","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2018.01.001","article-title":"Vascular function and cholecalciferol supplementation in CKD: a self-controlled case series","author":"Kumar","year":"2018","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.nefro.2018.07.004_bib0595","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.2215\/CJN.10791016","article-title":"Randomized controlled trial for the effect of vitamin D supplementation on vascular stiffness in CKD","volume":"12","author":"Levin","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nefro.2018.07.004_bib0600","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.2215\/CJN.01870217","article-title":"Cholecalciferol, calcitriol, and vascular function in CKD: a randomized, double-blind trial","volume":"12","author":"Kendrick","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nefro.2018.07.004_bib0605","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1160\/TH09-12-0814","article-title":"Phosphate and vascular calcification: emerging role of the sodium-dependent phosphate co-transporter PiT-1","volume":"104","author":"Lau","year":"2010","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.nefro.2018.07.004_bib0610","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1159\/000326903","article-title":"Vitamin D and vascular calcification in chronic kidney disease","volume":"34","author":"Rodriguez","year":"2011","journal-title":"Kidney Blood Press Res"},{"key":"10.1016\/j.nefro.2018.07.004_bib0615","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/MJT.0b013e3182211b3b","article-title":"Treatment of 25-OH vitamin D deficiency in older men with chronic kidney disease stages 3 and 4 is associated with reduction in cardiovascular events","volume":"20","author":"Lishmanov","year":"2013","journal-title":"Am J Ther"},{"key":"10.1016\/j.nefro.2018.07.004_bib0620","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/1471-2369-14-206","article-title":"Vitamin D insufficiency and deficiency with stages of chronic kidney disease in an Asian population","volume":"14","author":"Satirapoj","year":"2013","journal-title":"BMC Nephrol"}],"container-title":["Nefrolog\u00eda"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0211699518301231?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0211699518301231?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T00:01:19Z","timestamp":1546992079000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0211699518301231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0211699518301231"],"URL":"https:\/\/doi.org\/10.1016\/j.nefro.2018.07.004","relation":{},"ISSN":["0211-6995"],"issn-type":[{"value":"0211-6995","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]}}}